Loading...

PR Information Data

130 개 5 페이지
번호 컨텐츠
70 "AdipoLABs supports MOU between Dae-jeon University's Seoul Oriental Hospital and the United World Halal Development" : 2019.11.22 HOT 2019-11-22   3147 (주)아디포랩스
69 Challenge the global medical device market with proven clinical effects : 2019.02.01 HOT 2019-02-01   3187 (주)아디포랩스
68 Korea medical cancer treatment device REMISSION 1 ℃ introduced in India : 2019.01.28 HOT 2019-01-28   3201 (주)아디포랩스
67 AdipoLABs signs a business agreement with LG Twins : 2019.09.25 HOT 2019-09-25   3202 (주)아디포랩스
66 AdipoLABs supported Philippine medical team and Daejeon University Seoul Oriental Medicine Hospital’s meeting: 2019.11.12 HOT 2019-11-12   3209 (주)아디포랩스
65 South Korean CEO Promises Hopeful New Year : 2019.01.02 HOT 2019-01-02   3216 (주)아디포랩스
64 AdipoLABs, "we will definitely prove 'thermotherapy' in cancer and COVID-19" HOT 2020-05-28   3234 (주)아디포랩스
63 Changing medical device market, Han Sung-ho, CEO of AdipoLABs : 2018.10.1 HOT 2018-10-01   3247 (주)아디포랩스
62 The 7th Asian Congress of Hyperthermic Oncology(ACHO) was held : 2018.05.24 HOT 2018-05-24   3264 (주)아디포랩스
61 [KIMES 2019] AdipoLABs to Display 'REMISSION 1℃', High Frequency Hyperthermia Device for Medical Use : 2019.03.08 HOT 2019-03-08   3292 (주)아디포랩스
60 AdipoLABs wins ‘K-Medical Award’ for 4 consecutive years HOT 2020-05-27   3303 (주)아디포랩스
59 AdipoLABs‘ ‘REMISSION 1°C’ Becomes a New Hope for Cancer Patients Worldwide : 2018.11.23 HOT 2018-11-23   3308 (주)아디포랩스
58 AdipoLABs Establishes a Joint Venture in India to Enter Indian Market : 2018.09.06 HOT 2018-09-06   3318 (주)아디포랩스
57 REMISSION 1℃ Builds a Bridgehead for Entering Uzbekistan : 2019.11.28 HOT 2019-11-28   3328 (주)아디포랩스
56 AdipoLABs signed MOU with Sichuan Chengdu Nursing Service Association in China : 2019.12.06 HOT 2019-12-06   3342 (주)아디포랩스